Chemico-biological Interactions·Mar 9β-Nicotinamide mononucleotide prevents senescence and lipid accumulation in hepatic stellate cells by restoring SIRT1 functionExperiments in human cellsNicotinamide mononucleotidePaper
Zhonghua Gan Zang Bing Za Zhi·Mar 9Research progress on the quercetin target role and signaling pathway in anti-liver fibrosisReviewQuercetinPaper
BMC Gastroenterology·Mar 7Development of a liver stiffness measurement-based nomogram model to identify early CKD risk in patients with MAFLDCohort study of 1,328 peopleLiver stiffness measurementPaper
Journal of Medical Virology·Mar 6Changes in the Liver Fibrosis of Patients Who Develop Hepatocellular Carcinoma After a Sustained Virologic Response to Hepatitis C Virus InfectionCohort study of 6,047 peopleHepatocellular carcinomaPaper
Journal of Clinical Medicine·Feb 27Metabolic Dysfunction-Associated Steatotic Liver Disease and Sarcopenia: Review of LiteratureReviewMusclePaper
Life·Feb 27New Treatment Options for MASLD Patients with Type 2 DiabetesReviewMetabolic dysfunction-associated steatotic liver diseasePaper
Nutrition, Metabolism, and Cardiovascular Diseases·Feb 27Dynamic FIB-4 trajectory and a multi-state Markov model analysis reveal fibrosis progression and cardiovascular-cerebrovascular risk in MAFLD patientsCohort study of 5,777 peopleFIB-4Paper
Family Practice·Feb 26Can the Finnish Diabetes Risk Score (FINDRISC) be used to predict liver fibrosis risk instead of the fibrosis-4 index (FIB-4)?Cross-sectional study of 1,329 peopleFIB-4Paper
Canadian Liver Journal·Feb 23Prevalence and severity of MASLD and fibrosis using transient elastography: A cross-sectional screening in Lower Mainland, British Columbia, CanadaCross-sectional study of 2,782 peopleMetabolic dysfunction-associated steatotic liver diseasePaper
Scientific Reports·Feb 21Dynamic evaluation of blood marker changes induced by acute binge drinking in healthy individuals: a randomized controlled trialRandomized trial in 45 peopleAlcoholPaper
FASEB Journal·Feb 20Simvastatin Targets PKM2 to Alter Metabolic Reprogramming in Hepatic Stellate Cells and Mitigate Liver FibrosisExperiments in miceSimvastatinPaper
Advanced Materials·Feb 20Fusion Peptide-Incorporated Lipid Nanoparticles Boost Endosomal Escape and Enhance Cytosolic mRNA DeliveryExperiments in miceInterventionsPaper
The British Journal of Nutrition·Feb 18Antioxidant-rich and fibre-enhanced diets reduce liver fibrosis risk in metabolic dysfunction-associated steatotic liver disease: latent class analysis of a cohort studyCross-sectional study of 8,549 peopleLiver fibrosisPaper
International Journal of Biological Macromolecules·Feb 17The CFP macromolecule attenuates senescent liver sinusoidal endothelial cell-driven activation of hepatic stellate cellsExperiments in miceCellular senescencePaper
Endocrine·Feb 16The bidirectional relationship between diabetes mellitus and liver disease: Mechanisms, clinical implications, and management strategiesReviewMechanismsPaper
European Journal of Preventive Cardiology·Feb 16Effect of bempedoic acid on cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver diseaseRandomized trial in 13,970 peopleBempedoic acidPaper
European Journal of Medical Research·Feb 15Association of cardiovascular-kidney-metabolic syndrome stages with MASLD prevalence and liver fibrosis severity: evidence from traditional and machine learning approachesCross-sectional study of 3,084 peopleLiver fibrosisPaper
Tissue & Cell·Feb 13Protective effects of linagliptin and tenofovir disoproxil fumarate against APAP-induced acute liver injury: A biochemical, histological, and computational studyExperiments in miceTenofovir disoproxil fumaratePaper
JHEP Reports·Feb 123D endothelial cell scaffolds protect liver explants and exhibit therapeutic effects on liver fibrosisExperiments in 6 miceInterventionsPaper
The Indian Journal of Medical Research·Feb 6Screening for non-alcoholic fatty liver disease (NAFLD) among adults in Puducherry, India: A community-based cross-sectional studyCross-sectional study of 350 peopleMetabolic dysfunction-associated steatotic liver diseasePaper
Frontiers in Medicine·Feb 5Effect of SGLT-2 inhibitors on liver fibrosis progression in patients with MASLD: an updated meta-analysis based on RCTsMeta-analysis of randomized trialsSGLT2 inhibitorsPaper
The Kurume Medical Journal·Jan 29Circulating Thrombospondin-2 Levels Reflect Hepatic Fibrosis Severity and Renal Dysfunction in a General Population: Uku StudyCross-sectional study of 225 peopleRenal dysfunctionPaper
Pharmaceutics·Jan 28The Effect of GLP-1 Agonists on Patients with Metabolic-Associated Steatotic Liver Disease: A Systematic Review and Meta-AnalysisReviewInterventionsPaper
Journal of Clinical Medicine·Jan 28Physical Activity and Liver Fibrosis: A Stratified Analysis by Obesity and Diabetes StatusStudy in peoplePopulationsPaper
Heart Rhythm·Jan 28Liver fibrosis and sudden cardiac arrest: A prospective cohort study of 452,454 individualsStudy in peopleBiomarkersPaper
Frontiers in Endocrinology·Jan 26Liver fibrosis assessed via noninvasive liver fibrosis scores is associated with atherosclerotic cardiovascular disease in middle-aged and older patients with prediabetesStudy in peopleBiomarkersPaper
Advanced Science·Jan 25p16Ink4a-Positive Hepatocytes Drive Liver Fibrosis Through Activation of LIFR Family PathwayExperiments in miceCDKN2APaper
Zhonghua Liu Xing Bing Xue Za Zhi·Jan 22Liver function and distribution of liver fibrosis in older adults aged 65 years and above in 18 longevity areas in ChinaCross-sectional study of 5,403 peopleLiver fibrosisPaper
Journal of Physiology and Biochemistry·Jan 22Modulation of SIRT1/PPARγ pathways and tight junction proteins by nicotinamide riboside under chronic variable stressExperiments in 56 ratsNicotinamide ribosidePaper
Cureus·Jan 14Habitual Coffee Consumption and Systemic Health Outcomes: A Comprehensive ReviewReviewPopulationsPaper